CytoMed Therapeutics Limited (GDTC) Earning

$2.64

north_east
$0.06 (2.19%)
Day's range
$2.55
Day's range
$2.77

CytoMed Therapeutics Limited Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate

CytoMed Therapeutics Limited Earnings Date And Information

CytoMed Therapeutics Limited last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 290,560 for the year. CytoMed Therapeutics Limited has generated $0 earnings per share over the last year ($-0.29 diluted earnings per share) and currently has a price-to-earnings ratio of -11.27. CytoMed Therapeutics Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based on prior year's report dates.

CytoMed Therapeutics Limited Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
06/28/2024 Q2 2024 N/A -$0.07 N/A $0 $0
03/31/2024 Q1 2024 N/A -$0.04 N/A N/A $83,106
04/22/2024 Q4 2023 N/A -$0.06 N/A N/A $84,685
09/29/2023 Q3 2023 N/A -$0.06 N/A N/A $81,747
06/28/2023 Q2 2023 N/A -$0.14 N/A N/A $105,084
03/30/2023 Q1 2023 N/A -$0.08 N/A N/A $106,785
05/01/2023 Q4 2022 N/A -$0.14 N/A N/A $108,021
09/29/2022 Q3 2022 N/A -$0.09 N/A N/A $100,740
06/28/2022 Q2 2022 N/A -$0.00 N/A N/A $0
03/31/2022 Q1 2022 N/A -$0.05 N/A N/A $27,500
12/29/2021 Q4 2021 N/A $0.00 N/A N/A $0
09/30/2021 Q3 2021 N/A -$0.05 N/A N/A $31,379
06/28/2021 Q2 2021 N/A -$0.00 N/A N/A $0
03/31/2021 Q1 2021 N/A -$0.06 N/A N/A $10,638
12/31/2020 Q4 2020 N/A -$0.09 N/A N/A $22,512
09/30/2020 Q3 2020 N/A -$0.10 N/A N/A $21,781
06/30/2020 Q2 2020 N/A -$0.03 N/A N/A $0
03/31/2020 Q1 2020 N/A -$0.03 N/A N/A $0

CytoMed Therapeutics Limited Earnings: FAQ's

CytoMed Therapeutics Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based offlast year's report dates.

The conference call for CytoMed Therapeutics Limited's latest earnings report can be listened to online.

The conference call transcript for CytoMed Therapeutics Limited's latest earnings report can be read online.

CytoMed Therapeutics Limited (:GDTC) has a recorded annual revenue of $290,560.

CytoMed Therapeutics Limited (:GDTC) has a recorded net income of $-3,131,788.CytoMed Therapeutics Limited has generated $-0.29 earnings per share over the last four quarters.

CytoMed Therapeutics Limited (:GDTC) has a price-to-earnings ratio of -11.27 and price/earnings-to-growth ratio is -0.79.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED